WEALTH ENHANCEMENT ADVISORY SERVICES, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1632972
PLYMOUTH, MN
Position in VRTX
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$22,794,442
+$4,634,554 QoQ
Shares Held
45,889
+12.8% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#247
of 1,742 holders
Holding Since
Jun 2020
20 quarters on record
Voting authority
Sole 6%
Shared 0%
None 94%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Derivatives in VRTX
reported options exposure · as of Sep 30, 2024CallValue
$216,780
CallShares
5,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $166,117,226 across 147 Biotechnology names. VRTX ranks #1 (13.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
45,889 | $22,794,442 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
33,880 | $21,125,535 | |
| 3 | INCY |
Incyte Corp
|
151,505 | $17,174,606 | |
| 4 | EXEL |
Exelixis, Inc.
|
207,728 | $11,302,480 | |
| 5 | RPRX |
Royalty Pharma plc
|
179,888 | $10,086,320 | |
| 6 | CORT |
Corcept Therapeutics Inc
|
76,278 | $6,632,372 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
70,797 | $5,541,281 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
19,919 | $4,875,573 |
All Filings in VRTX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,794,442 | 45,889 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $18,159,888 | 40,668 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $36,833,686 | 81,246 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $28,773,399 | 73,469 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $36,791,773 | 82,641 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $38,877,230 | 80,189 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $32,292,110 | 80,189 | Shares | Sole | 2025-03-17 | |
| 2024-09-30 | $216,780 | 5,100 | Call | Sole | 2024-10-24 | |
| 2024-09-30 | $47,387,466 | 101,891 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $40,128,056 | 85,612 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $34,291,868 | 82,036 | Shares | Sole | 2024-04-15 | |
| 2024-03-31 | $46,620 | 1,400 | Call | Sole | 2024-04-15 | |
| 2023-12-31 | $152,010 | 4,500 | Call | Sole | 2024-01-30 | |
| 2023-12-31 | $30,506,577 | 74,975 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $16,548,598 | 47,589 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,488,131 | 9,912 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $3,080,754 | 9,778 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $2,799,433 | 9,694 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $3,827,429 | 13,219 | Shares | Sole | 2022-10-17 | |
| 2022-03-31 | $5,969,427 | 22,874 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $4,840,642 | 22,043 | Shares | Sole | 2022-02-08 | |
| 2020-09-30 | $1,883,070 | 6,920 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $3,619,294 | 12,467 | Shares | Sole | 2020-10-13 | |
| No filing history on record for this holder in this stock. | ||||||